Clinical Trials Logo

Complications; Cesarean Section clinical trials

View clinical trials related to Complications; Cesarean Section.

Filter by:

NCT ID: NCT01858467 Completed - Clinical trials for Complications; Cesarean Section

Supreme LMA and Endotracheal Intubation Use in Caesarean Section

Start date: May 2013
Phase: N/A
Study type: Interventional

The LMA Supreme (SLMA) is a single-use supraglottic device that provides a good seal for positive pressure ventilation and good first attempt insertion rate of 98% in low-risk patients undergoing Caesarean section. It has a double aperture design that facilitates the introduction of an orogastric tube to aspirate gastric contents. The current practice is to use endotracheal intubation with rapid sequence induction in general anaesthesia for Caesarean section. The primary study hypothesis is the first attempt insertion success rate of SLMA and endotracheal intubation are equivalent with a difference of less than 3%.

NCT ID: NCT01851187 Completed - Clinical trials for Complications; Cesarean Section

Effect of Perinatal Emotional Management on Maternal Emotion and Delivery Outcomes

Start date: September 2008
Phase: N/A
Study type: Interventional

Pregnancy or childbirth is a kind of persistent and strong source of stress for pregnant women. Prenatal and intrapartum negative emotions not only damage the mental health of pregnant women, but also have a negative impact on the mode of delivery, labor, postpartum complications and neonatal outcomes . Due to considerations for the effect on the fetus, there is concern of the use of drug treatment for depression during pregnancy. Therefore, psychological interventions have an important role. According to the WHO global survey in Asia 2007-08, China had the highest overall rate of caesarean section (46.2%), and also had the highest rate of caesarean section without indication (11.7%). The embarrassing "first in the world" of caesarean section rate was causing widespread concern in China. Recently, the Chinese government has launched a project named "promoting the rate of natural childbirth and protecting the health of mother and child", trying to reduce the cesarean section rate especially that without medical indication. Therefore, examining if emotional management is effective in reducing negative emotions of pregnant women as well as decreasing the rate of cesarean section is an important research question. Our study aims to help the pregnant women control their anxiety, depressive feelings and other negative emotions by "emotional self-management group training" and we examine if this can reduce the incidence of depression and improve delivery outcomes.

NCT ID: NCT01741610 Completed - Clinical trials for Complications; Cesarean Section

Fluid Coloading and the Incidence of Hypotension

Start date: October 2008
Phase: Phase 4
Study type: Interventional

This study was conducted to evaluate the effects of rapid crystalloid (Lactated Ringer's solution) or colloid (hydroxyethyl starch; HES) cohydration with a second intravenous access line on the incidence of hypotension and ephedrine requirement during spinal anaesthesia for caesarean section.

NCT ID: NCT01739543 Completed - Clinical trials for Complications; Cesarean Section

A Reduction in C-section Rates Using the Hem-Avert Perianal Stabilizer

Start date: April 2012
Phase: N/A
Study type: Interventional

A REDUCTION IN C-SECTION RATES USING THE HEM-AVERT® PERIANAL STABILIZER.

NCT ID: NCT01735669 Completed - Clinical trials for Pregnancy Complications

Open Randomized Controlled Trial to Evaluate the Efficacy and Safety of Remifentanil Versus Nitrous Oxide in External Cephalic Version at Term in Singleton Pregnancy in Breech Presentation

REMIVER
Start date: July 2012
Phase: Phase 3
Study type: Interventional

Objectives: The objective is to demonstrate the superiority of remifentanil versus nitrous oxide as adjuvant analgesic treatment to increase the chances of success of external cephalic version in the management of non-cephalic presentation in women with singleton pregnancy at term. Another objective is to compare their safety, tolerability and acceptability. Methodology: single-center clinical trial, randomized, open, parallel-group and sequential design, with active comparator. Pragmatic approach. Sequential design of O'Brien-Fleming with two interim analysis. Analysis by intention to treat. Comparison of the rate of successful version, referred to analgesic effect, safety, caesarean rates and acceptability rate of the procedure for pregnant women.

NCT ID: NCT01723605 Completed - Clinical trials for Complications; Cesarean Section

Insitu Repair Versus Uterine Exeriorization During Cesarean Section

Start date: October 2012
Phase: Phase 3
Study type: Interventional

Two types of uterine repair described during cesarean section, the investigators will try to compare between the two techniques.

NCT ID: NCT01665027 Completed - Clinical trials for Complications; Cesarean Section

Effect of Vacuum on Fetal and Maternal Complications During Difficult Caesarean Section

Start date: December 2010
Phase: Phase 3
Study type: Interventional

The Cesarean Section (C/S) rate from 1970 to 2007 in U.S is 31.8% and in Iran From 2000 to 2009 rose to 50-65%. This Surgical Procedure is not without risk. Difficult head Extraction in C/S occur in 1-2% of all deliveries. This study was designed to compare the results of delivery by vacuum in C/S with normal caesarean section.

NCT ID: NCT01509521 Completed - Clinical trials for Complications; Cesarean Section

The Oxygenation of the Brain During Caesarean Section

OBDUC
Start date: February 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the impact of phenylephrine versus ephedrine on organ perfusion, in women undergoing caesarean section receiving spinal anaesthesia. The organ perfusion is estimated by measuring the maternal cerebral oxygenation by NIRS(Near-infrared spectroscopy)and the foetal heartrate.

NCT ID: NCT01412073 Completed - Clinical trials for Complications; Cesarean Section

Control of Blood Loss During Caesarean Section

Start date: September 2011
Phase: Phase 3
Study type: Interventional

trial of 3 protocols to determine the best one to control blood loss during caesarean section

NCT ID: NCT00891150 Completed - Clinical trials for Complications; Cesarean Section

Oxytocin to Decrease Blood Loss During Cesarean Section

Start date: July 2012
Phase: N/A
Study type: Interventional

The goal of this study is to determine the best dose of a drug called oxytocin, that is usually used to stop bleeding during a delivery, when used during a cesarean delivery. It will be administered during cesarean section in order to decrease the amount blood loss. The investigators are proposing to have 3 groups of subjects each given a different safe dose of oxytocin and then to assess the effectiveness of each regimens on the amount blood lost during cesarean sections.This will let use know which is the best lowest dose needed.